Evaluating iatrogenic prescribing: development of an oncology-focused trigger tool.
Hébert G, Netzer F, Ferrua M, Ducreux M, Lemare F, Minvielle E. Eur J Cancer. 2015;51:427-435.
This study describes the development and validation of an oncology trigger tool, modeled after the Institute for Healthcare Improvement's Global Trigger Tool, to capture adverse drug events during cancer care. The final tool included 22 triggers and achieved high interrater reproducibility, but had only a modest 20% positive predictive value.
Chemotherapy safety and severe adverse events in cancer patients: strategies to efficiently avoid chemotherapy errors in in- and outpatient treatment.
Markert A, Thierry V, Kleber M, Behrens M, Engelhardt M. Int J Cancer. 2009;124:722-728.
Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costs.
Ranchon F, Salles G, Späth HM, et al. BMC Cancer. 2011;11:478.
Is oral chemotherapy prescription safe for patients? A cross-sectional survey.
Bourmaud A, Pacaut C, Melis A, et al. Ann Oncol. 2014;25:500-504.
STUDYView all related resources...
Improving cancer patient care with combined medication error reviews and morbidity and mortality conferences.
Ranchon F, You B, Salles G, et al. Chemotherapy. 2014;59:330-337.